The PRESERFLO MicroShunt presents a less invasive method for managing intraocular pressure in glaucoma patients. However, recent findings from a study published in Graefe's Archive for Clinical and Experimental Ophthalmology reveal that petrolatum-based ophthalmic ointments significantly heighten the risk of swelling and structural failure of the device. Clinical cases showed that exposure to these ointments resulted in significant complications, urging clinicians to avoid their use in scenarios where the MicroShunt may be compromised.
1. PRESERFLO MicroShunt is an alternative to trabeculectomy for glaucoma. 2. Petrolatum-based ointments may cause swelling and structural failure of the MicroShunt. 3. Cases showed complications linked to ointment exposure post-surgery. 4. Optical coherence tomography revealed localized swelling effects. 5. Clinicians should avoid ointment use if the MicroShunt is exposed or if conjunctival integrity is compromised.
Listen Tab content
